Literature DB >> 8778448

Liver transplantation for hepatic cirrhosis in cystic fibrosis.

G Noble-Jamieson1, N Barnes, N Jamieson, P Friend, R Calne.   

Abstract

About 10% of children with CF develop hepatic cirrhosis and progressive portal hypertension. As the portal hypertension worsens these children are likely to develop serious variceal bleeding and other complications including malnutrition and a decline in respiratory function. Indices of lung function may fall as much as 50% in a year and chest infections may require frequent admissions to hospital. The respiratory symptoms are often attributed to CF related lung disease and affected children may therefore be considered unsuitable for liver transplantation. We propose a simple scoring system which can help to select patients who should be referred for assessment of liver transplantation. After careful assessment and preparation children with lung function indices as low as 30% predicted can have a successful outcome after liver transplantation. With good graft function portal hypertension is relieved and absorption, nutrition and respiratory function all improve. The improved quality of life of these children is remarkable.

Entities:  

Mesh:

Year:  1996        PMID: 8778448      PMCID: PMC1295623     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  23 in total

1.  Liver and biliary problems in cystic fibrosis.

Authors:  M S Tanner
Journal:  J R Soc Med       Date:  1992       Impact factor: 5.344

2.  Successful liver transplantation in babies under 1 year.

Authors:  S V Beath; G D Brook; D A Kelly; A J Cash; P McMaster; A D Mayer; J A Buckels
Journal:  BMJ       Date:  1993-10-02

3.  High strength pancreatic exocrine enzyme capsules associated with colonic strictures in patients with cystic fibrosis: "more is not necessarily better".

Authors:  E Lebenthal
Journal:  J Pediatr Gastroenterol Nutr       Date:  1994-05       Impact factor: 2.839

4.  Liver transplantation for hepatic cirrhosis in cystic fibrosis.

Authors:  G Noble-Jamieson; J Valente; N D Barnes; P J Friend; N V Jamieson; A Rasmussen; R Y Calne
Journal:  Arch Dis Child       Date:  1994-10       Impact factor: 3.791

5.  Bile-duct destruction and collagen deposition: a prominent ultrastructural feature of the liver in cystic fibrosis.

Authors:  A Lindblad; R Hultcrantz; B Strandvik
Journal:  Hepatology       Date:  1992-08       Impact factor: 17.425

Review 6.  Management of variceal haemorrhage.

Authors:  S G Williams; D Westaby
Journal:  BMJ       Date:  1994-05-07

7.  Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells.

Authors:  J A Cohn; T V Strong; M R Picciotto; A C Nairn; F S Collins; J G Fitz
Journal:  Gastroenterology       Date:  1993-12       Impact factor: 22.682

8.  Effect of high-dose ibuprofen in patients with cystic fibrosis.

Authors:  M W Konstan; P J Byard; C L Hoppel; P B Davis
Journal:  N Engl J Med       Date:  1995-03-30       Impact factor: 91.245

9.  Intrapulmonary shunting in the biliary atresia/polysplenia syndrome: reversal after liver transplantation.

Authors:  M S Fewtrell; G Noble-Jamieson; S Revell; J Valente; P Friend; P Johnston; A Rasmussen; N Jamieson; R Y Calne; N D Barnes
Journal:  Arch Dis Child       Date:  1994-06       Impact factor: 3.791

10.  Analysis of risk factors for the development of liver disease associated with cystic fibrosis.

Authors:  C Colombo; M G Apostolo; M Ferrari; M Seia; S Genoni; A Giunta; L P Sereni
Journal:  J Pediatr       Date:  1994-03       Impact factor: 4.406

View more
  7 in total

1.  Does splenectomy in cystic fibrosis related liver disease improve lung function and nutritional status? A case series.

Authors:  B Linnane; M R Oliver; P J Robinson
Journal:  Arch Dis Child       Date:  2006-05-31       Impact factor: 3.791

Review 2.  The gallbladder and biliary tract in cystic fibrosis.

Authors:  Michael P Curry; John E Hegarty
Journal:  Curr Gastroenterol Rep       Date:  2005-05

3.  Liver: Benefit of liver transplantation in patients with cystic fibrosis.

Authors:  Bruno Gridelli
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-03-08       Impact factor: 46.802

4.  Partial splenectomy in cystic fibrosis patients with hypersplenism.

Authors:  G H Thalhammer; E Eber; S Uranüs; J Pfeifer; M S Zach
Journal:  Arch Dis Child       Date:  2003-02       Impact factor: 3.791

Review 5.  Interventions for preventing and managing advanced liver disease in cystic fibrosis.

Authors:  Senthil K Palaniappan; Nan Nitra Than; Aung Win Thein; Soe Moe; Indra van Mourik
Journal:  Cochrane Database Syst Rev       Date:  2017-08-29

Review 6.  Cirrhosis and other liver disease in cystic fibrosis.

Authors:  Thomas Flass; Michael R Narkewicz
Journal:  J Cyst Fibros       Date:  2012-12-20       Impact factor: 5.482

7.  Cystic Fibrosis Associated with Worse Survival After Liver Transplantation.

Authors:  Sylvester M Black; Frederick W Woodley; Dmitry Tumin; Khalid Mumtaz; Bryan A Whitson; Joseph D Tobias; Don Hayes
Journal:  Dig Dis Sci       Date:  2015-11-24       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.